Skip to main content

What the FDA labels say about taking them together

Digoxin and erythromycin

Erythromycin's FDA label of August 1, 2024 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name erythromycin. The erythromycin label: “Concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels.”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the erythromycin FDA label on DailyMed (effective August 1, 2024, Teva Pharmaceuticals USA, Inc.).

What does the digoxin label say about erythromycin?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name erythromycin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the erythromycin label say about digoxin?

Erythromycin label, drug interactions

Concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels.

Source: FDA drug label (Erythromycin), Teva Pharmaceuticals USA, Inc., effective August 1, 2024 (SPL set 75a0bd5a-d09f-483b-bfd8-f8343b149eb2), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
38Erythromycin generic labelers
DigoxinErythromycin
Labeled forHeart failure, Atrial fibrillationBacterial infections, Acne
Boxed warningNoNo
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tablet$1.96 per tablet 250 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?